High-throughput simultaneous screen and counterscreen identifies homoharringtonine as synthetic lethal with von Hippel-Lindau loss in renal cell carcinoma

Nicholas C. Wolff(The University of Texas Southwestern Medical Center), James Brugarolas(Harold C. Simmons Comprehensive Cancer Center)
Oncotarget
July 3, 2015
Cited by 34


Related Papers